Takeda Pharmaceutical Company Limited TKPHF
Set alert
42.00 USD +4.03 +10.61%
At close · Oct 30
42.00 Day range 42.00
26.44 52-week range 42.00
- YTD
- +36.23%
- 1 year
- +51.46%
- Open
- 42.00
- Prev close
- 37.97
- Mkt cap
- 67.09B
- Vol
- 125
- Avg vol
- 4.49K
- EPS
- 0.14
- P/E
- 300.00
More statistics
- Low
- 42.00
- High
- 42.00
- Earnings
- Oct 29, 2026
3M chart
Events in this range
- Sep 29, 2026Dividend: 0.648
- Sep 30, 2026Dividend: 0.6486
- Oct 29, 2026Earnings: —; estimate 0.2915; surprise —%
Signals (21)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 31, 2026 | 3 months ago |
Financial health
Altman Z-Score
1.39 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E 44.5×
FY 2016 5y median 44.5× FY 2025
P/S 1.9×
FY 2016 5y median 1.6× FY 2025
P/B 1.1×
FY 2016 5y median 1.1× FY 2025
P/FCF 11.2×
FY 2016 5y median 11.2× FY 2025
EV/EBITDA 10.2×
FY 2016 5y median 10.2× FY 2025
EV/Sales 2.9×
FY 2016 5y median 2.6× FY 2025
FCF Yield 8.9%
FY 2016 5y median 8.9% FY 2025
Profitability
Gross Margin 51.1%
FY 2016 5y median 66.4% FY 2025
Operating Margin 12.0%
FY 2016 5y median 12.0% FY 2025
Net Margin 4.3%
FY 2016 5y median 4.3% FY 2025
ROE 2.5%
FY 2016 5y median 2.5% FY 2025
ROIC 2.9%
FY 2016 5y median 2.9% FY 2025
ROA 1.2%
FY 2016 5y median 1.2% FY 2025
Growth (YoY)
Revenue -1.0%
FY 2016 FY 2025
Operating Income 58.7%
FY 2016 FY 2025
EPS (diluted) 78.3%
FY 2016 FY 2025
Free Cash Flow 13.3%
FY 2016 FY 2025
Financial Health
Current Ratio 1.3×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 0.7×
FY 2016 5y median 0.6× FY 2025
Debt / Equity 0.6×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 3.4×
FY 2016 5y median 3.5× FY 2025
Interest Coverage 1.5×
FY 2016 5y median 2.5× FY 2025
Dividends
Dividend Yield 3.6%
FY 2016 5y median 4.1% FY 2025
Payout Ratio 162.7%
FY 2016 5y median 162.7% FY 2025
Annual · latest fiscal year ends 2026-03-31